Insider trading

Period: 120 months Stock: BTAI Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

38 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

38 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

38 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

38 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
38 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
38 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

38 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
20 May 2026
Yocca Frank Chief Scientific Officer
Sold on a plan
$7.43K 6,845 at 1.09
20.7%
Planned (10b5-1)
20 May 2026
Rodriguez Javier See Remarks
Sold on a plan
$7.11K 6,560 at 1.08
19.7%
Planned (10b5-1)
16 Dec 2024
Rodriguez Javier See Remarks
Sold on a plan 2×
$153.02 430 at 0.36
1.7%
Planned (10b5-1)
16 Dec 2024
Yocca Frank Chief Scientific Officer
Sold on a plan 2×
$151.82 430 at 0.35
1.5%
Planned (10b5-1)
16 Dec 2024
O'Neill Vincent See Remarks
Sold on a plan
$58.13 165 at 0.35
0.8%
Planned (10b5-1)
3 Oct 2024
Yocca Frank Chief Scientific Officer
Sold on a plan
$3.95K 7,175 at 0.55
20.2%
Planned (10b5-1)
3 Oct 2024
Rodriguez Javier See Remarks
Sold on a plan
$3.77K 6,863 at 0.55
22.4%
Planned (10b5-1)
3 Oct 2024
Wiley Matthew T. Chief Commercial Officer
Sold on a plan
$3.45K 6,272 at 0.55
24.8%
Planned (10b5-1)
3 Oct 2024
O'Neill Vincent See Remarks
Sold on a plan
$3.06K 5,556 at 0.55
22.1%
Planned (10b5-1)
16 Sep 2024
Yocca Frank Chief Scientific Officer
Sold on a plan
$244.70 355 at 0.69
2.4%
Planned (10b5-1)
16 Sep 2024
Rodriguez Javier See Remarks
Sold on a plan
$238.05 345 at 0.69
3.6%
Planned (10b5-1)
16 Sep 2024
Wiley Matthew T. Chief Commercial Officer
Sold on a plan
$148.52 215 at 0.69
5.1%
Planned (10b5-1)
16 Sep 2024
O'Neill Vincent See Remarks
Sold on a plan
$95.33 138 at 0.69
3.4%
Planned (10b5-1)
17 Jun 2024
Yocca Frank Chief Scientific Officer
Sold on a plan
$476.16 372 at 1.28
2.7%
Planned (10b5-1)
17 Jun 2024
Rodriguez Javier See Remarks
Sold on a plan
$456.02 361 at 1.26
4.1%
Planned (10b5-1)
17 Jun 2024
Wiley Matthew T. Chief Commercial Officer
Sold on a plan
$308.10 244 at 1.26
6.5%
Planned (10b5-1)
17 Jun 2024
O'Neill Vincent See Remarks
Sold on a plan
$199.18 155 at 1.29
4.2%
Planned (10b5-1)
4 Apr 2024
Yocca Frank Chief Scientific Officer
Sold on a plan
$2.81K 1,067 at 2.64
7.7%
Planned (10b5-1)
4 Apr 2024
Rodriguez Javier See Remarks
Sold on a plan
$2.67K 1,012 at 2.64
11.7%
Planned (10b5-1)
4 Apr 2024
Wiley Matthew T. CHIEF COMMERCIAL OFFICER
Sold on a plan
$2.66K 1,008 at 2.64
25.2%
Planned (10b5-1)
4 Apr 2024
O'Neill Vincent See Remarks
Sold on a plan
$432.48 165 at 2.62
3.0%
Planned (10b5-1)
15 May 2023
Rodriguez Javier See Remarks
Sold on a plan
$48.76K 1,785 at 27.32
29.1%
Planned (10b5-1)
15 Mar 2023
Yocca Frank Chief Scientific Officer
Sold, plan not stated
$19.40K 985 at 19.69
9.4%
15 Mar 2023
Rodriguez Javier See Remarks
Sold, plan not stated
$18.64K 950 at 19.63
45.6%
15 Mar 2023
O'Neill Vincent Chief Medical Officer
Sold, plan not stated
$16.64K 845 at 19.70
40.5%
20 Jan 2023
Yocca Frank Chief Scientific Officer
Sold, plan not stated
$1.50M 50,000 at 30.00
85.6%
Sold half or more
20 Jan 2023
O'Neill Vincent Chief Medical Officer
Sold, plan not stated
$891.39K 29,713 at 30.00
100%
Sold half or more
15 Mar 2021
Yocca Frank Chief Scientific Officer
Sold, plan not stated 2×
$727.57K 15,000 at 48.50
20.4%
17 Feb 2021
O'Neill Vincent Chief Medical Officer
Sold, plan not stated 5×
$1.39M 25,000 at 55.58
100%
Sold half or more
16 Feb 2021
Yocca Frank Chief Scientific Officer
Sold, plan not stated 7×
$865.15K 15,000 at 57.68
17.0%
25 Jan 2021
Yocca Frank Chief Scientific Officer
Sold, plan not stated 4×
$725.81K 15,000 at 48.39
14.5%
19 Jan 2021
O'Neill Vincent Chief Medical Officer
Sold, plan not stated 5×
$1.24M 25,000 at 49.47
100%
Sold half or more
28 Dec 2020
O'Neill Vincent Chief Medical Officer
Sold, plan not stated 4×
$1.29M 25,000 at 51.45
100%
Sold half or more
13 Aug 2019
Yocca Frank Chief Scientific Officer
Bought
$56.76K 6,547 at 8.67
354%
First buy on file
4 Dec 2018
Yocca Frank Chief Scientific Officer
Bought
$2.34K 450 at 5.20
32.1%
First buy on file
3 Dec 2018
Yocca Frank Chief Scientific Officer
Bought
$2.35K 450 at 5.23
47.4%
First buy on file
30 Nov 2018
Yocca Frank Chief Scientific Officer
Bought
$2.34K 450 at 5.20
90.0%
First buy on file
29 Nov 2018
Yocca Frank Chief Scientific Officer
Bought
$2.51K 500 at 5.02
opened
First buy on file
Showing 1–38 of 38.